The results of the examination of subgroups based mainly on the nodal metastasis, the nature of most cancer stages, and the grade of tumors suggested that the MFAP2 mRNA grades of STAD patients were substantially higher than the corresponding group. The gene discussed is MFAP2; the disease is cancer.